Shockwave Medical Provides Quarterly Earnings Release Dates for 2023

Rhea-AI Summary

Shockwave Medical (Nasdaq: SWAV) announced the schedule for its upcoming quarterly earnings releases and conference calls for 2023. Earnings for Q4 2022 will be released on February 16, 2023, at 4:30 p.m. ET, followed by Q1 on May 8, Q2 on August 7, and Q3 on November 6, all at 4:30 p.m. ET. These events will be accessible via dial-in and webcast. The company is committed to innovating treatment for calcified cardiovascular disease through its Intravascular Lithotripsy (IVL) technology, aimed at improving patient outcomes.

Positive

• Scheduled earnings calls provide transparency for investors.
• Shockwave Medical's IVL technology positions them uniquely in the cardiovascular treatment market.

Negative

• None.

SANTA CLARA, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that it expects to issue quarterly earnings releases after the market closes and hold conference calls at the times indicated on the following dates:

Fourth Quarter 2022 Earnings – Thursday, February 16, 2023 at 4:30 p.m. (ET)
First Quarter 2023 Earnings – Monday, May 8, 2023 at 4:30 p.m. (ET)
Second Quarter 2023 Earnings – Monday, August 7, 2023 at 4:30 p.m. (ET)
Third Quarter 2023 Earnings – Monday, November 6, 2023 at 4:30 p.m. (ET)

Investors interested in listening to the fourth quarter 2022 conference call at 4:30 p.m. eastern time on Thursday, February 16, 2023, may do so by dialing (877) 704-4453 for domestic callers or (201) 389-0920 for international callers, using conference ID: 13734496. Live and archived webcasts of all earnings events will also be made available at https://ir.shockwavemedical.com.

Dial-in information for future earnings calls will be provided at later dates.

About Shockwave Medical, Inc.
Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.

Media Contact:
Scott Shadiow
sshadiow@shockwavemedical.com

Investor Contact:
Debbie Kaster
dkaster@shockwavemedical.com

FAQ

When will Shockwave Medical report Q4 2022 earnings?

Shockwave Medical will report Q4 2022 earnings on February 16, 2023, at 4:30 p.m. ET.

What is the schedule for Shockwave Medical's earnings calls in 2023?

The earnings calls are scheduled for February 16, May 8, August 7, and November 6, 2023, all at 4:30 p.m. ET.

How can I listen to the earnings calls for Shockwave Medical?

You can listen to the earnings calls by dialing (877) 704-4453 for domestic callers or (201) 389-0920 for international callers, using conference ID: 13734496.

What technology does Shockwave Medical focus on?

Shockwave Medical focuses on developing Intravascular Lithotripsy (IVL) to treat calcified cardiovascular disease.